（文章来源：证券日报） 证券日报网讯 12月4日，贝斯美在互动平台回答投资者提问时表示，公司目前经营正常，产能利用充 足。 ...

Core Viewpoint - The company, Bestme, announced that it and its subsidiaries do not provide guarantees to entities outside the scope of consolidated financial statements, do not have overdue guarantees, and are not involved in any litigation related to guarantees, nor are they liable for losses due to any adverse judgments related to guarantees [2] Summary by Relevant Categories - **Guarantees** - The company and its subsidiaries do not provide guarantees to entities outside the scope of consolidated financial statements [2] - There are no overdue guarantees reported [2] - The company is not involved in any litigation concerning guarantees [2] - **Legal and Financial Liabilities** - There are no situations where the company has been judged to bear losses due to guarantees [2]

证券代码：300796 证券简称：贝斯美 公告编号：2025-084 绍兴贝斯美化工股份有限公司 关于为控股子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 一、担保情况概述 绍兴贝斯美化工股份有限公司(以下简称"公司"或"绍兴贝斯美 ") 分别于 2025年4月18日和2025年5月9日，召开了第四届董事会第三次会议和2024年年度股东 大会，审议通过了《关于公司预计2025年度为子公司提供担保额度的议案》，根据 公司经营发展的需要，2025年度公司预计为公司合并报表范围内子公司银行综合授 信业务提供不超过10.27亿元人民币的担保，其中为控股子公司铜陵贝斯美科技有限 公司（以下简称"铜陵贝斯美"）提供的担保预计不超过6.07亿元人民币。担保额 度有效期自2024年年度股东大会审议通过之日起12个月。具体内容详见公司2025年4 月19日披露于巨潮资讯网(www.cninfo.com.cn ) 上的《关于预计2025年度为子公司 提供担保额度的公告》（公告编号2025-028）。 二、担保进展情况 1、铜陵贝斯美的基本信息 1 | 公 ...

Group 1 - The core stock price of Beishimei increased by 2.07% on November 19, reaching 9.86 CNY per share, with a total market capitalization of 3.561 billion CNY [1] - The company experienced a stock price decline of 3.43% year-to-date, but saw a 1.75% increase over the last five trading days and a 2.28% increase over the last 20 days, while it dropped 19.51% over the last 60 days [2] - As of September 30, the number of shareholders decreased by 9.41% to 18,000, with an average of 20,046 circulating shares per person, which increased by 10.39% [2] Group 2 - Beishimei's main business includes the research, production, and sales of products such as 4-nitro intermediates, dimethenamid-p active ingredients, and dimethenamid-p formulations, with the main revenue sources being dimethenamid-p active ingredients (25.95%) and various trade pesticides [2] - For the period from January to September 2025, Beishimei achieved operating revenue of 1.11 billion CNY, representing a year-on-year growth of 14.29%, and a net profit attributable to shareholders of 31.17 million CNY, reflecting a significant year-on-year increase of 1257.94% [2] - The company has distributed a total of 62.87 million CNY in dividends since its A-share listing, with 38.52 million CNY distributed over the past three years [3]

Core Viewpoint - The company has achieved stable production and bulk sales of its cyclopentane products, leveraging the synergies of the carbon five industry chain and its technological accumulation to enhance market space and profitability [2] Group 1: Production and Sales - The company has successfully stabilized the production of cyclopentane products and is now engaged in bulk sales [2] - The cyclopentane products are primarily used in refrigerants and foaming agents [2] Group 2: Competitive Advantages - The company benefits from the consistency in quality and batch uniformity across production stages, ensuring reliable supply periods [2] - By reducing intermediary transaction costs, the company effectively expands its market space and enhances profitability [2] - The company has formed a cost advantage and optimized product structure through its operational efficiencies [2]

Key Points - A new stock subscription is available today [1] - The State Council meeting on October 31 focused on deepening reforms in key areas and expanding institutional openness [3] - The Ministry of Finance and the State Taxation Administration announced tax policies related to gold trading, exempting VAT until the end of 2027 for certain transactions [3] - The China Securities Regulatory Commission released draft guidelines for the performance benchmarks of publicly offered securities investment funds [4] - A significant breakthrough in nuclear energy was reported, with China achieving thorium-uranium fuel conversion based on molten salt reactors [4] - The China Listed Companies Association reported improved performance among listed companies, highlighting the role of innovation and structural upgrades [5] - The 15th National Games torch relay featured a humanoid robot "Kua Fu" as a torchbearer, marking a global first [5] - Anshi China has established sufficient inventory to meet customer demand through the end of the year and beyond [7] - Vanke A is set to receive a loan of up to 22 billion yuan from Shenzhen Metro Group [7] - Long-term growth in new energy vehicle sales was reported for Chang'an Automobile and Seres [7] - Great Wall Motors reported October sales of 143,100 vehicles, a year-on-year increase of 22.5% [8] - ST Yifei signed an overseas procurement order worth approximately 190 million yuan [9] - Tianqi Co. signed a strategic cooperation framework agreement with Foxconn Automotive [10] - Several companies are undergoing significant changes, including mergers and acquisitions, and stock repurchases [13][14][15][16]

Core Insights - The company, Beishimei, reported impressive financial results for the first three quarters of 2025, with a revenue of 1.11 billion yuan, a year-on-year increase of 14.29%, and a net profit of 31 million yuan, reflecting a significant growth of 1,257.94% [1] - The company's dual strategy of focusing on its core business of Dimethenamid-P and extending into carbon five new materials has driven its performance, supported by a fully integrated supply chain that creates cost and technological barriers [1][2] Financial Performance - For the first nine months of 2025, the company achieved a net cash flow from operating activities of 75.56 million yuan, up 26.28% year-on-year, indicating improved operational efficiency [1] - The revenue for 2024 and the first half of 2025 was reported at 1.328 billion yuan and 776 million yuan, respectively, with overseas business contributing significantly to the revenue [4] Business Model and Competitive Advantage - Beishimei is the only domestic company with a complete production and R&D capability for Dimethenamid-P, covering the entire supply chain from raw materials to formulations [2] - The company has established a strong competitive moat through its integrated supply chain, which includes a production capacity of 12,000 tons for raw materials and 8,000 tons for intermediates [2][3] Market Demand and Industry Outlook - The global pesticide market is projected to grow from 79.06 billion USD in 2024 to 118.51 billion USD by 2031, with China expected to capture over 60% of the incremental growth [3] - The demand for efficient, low-toxicity, and environmentally friendly pesticides remains strong due to global population growth and food security concerns [3] Global Expansion Strategy - The company has expanded its global market presence through the acquisition of Ningbo Jielike, which has 1,129 overseas pesticide registration certificates, allowing it to export to 79 countries and regions [4] - In 2025, overseas business accounted for 73.58% of total revenue, highlighting the company's successful international strategy [4] New Growth Areas - Beishimei is actively developing high-value new materials, with projects in place for producing green materials such as ketones and cyclopentane, which are expected to enhance its competitive edge [5] - Revenue from carbon five series products reached 73.12 million yuan in 2024 and 61.24 million yuan in the first half of 2025, marking year-on-year growth of 526.11% and 141.83%, respectively [5]

Summary of Key Points Core Viewpoint - Several companies are experiencing significant shareholder reductions, with some facing regulatory scrutiny for financial discrepancies [1] Group 1: Shareholder Reductions - Aohua Endoscopy's general manager Gu Xiaozhou plans to reduce holdings by no more than 2.6 million shares [1] - Tuosida's senior executive Huang Daibo intends to reduce holdings by no more than 0.9524% of shares [1] - Anke Intelligent Electric's actual controller Chen Xiaohui plans to reduce holdings by no more than 1% [1] - Shanhe Pharmaceutical's shareholder Fosun Pharma intends to reduce holdings by no more than 3% [1] - Digital Certification's shareholder Capital Information Development plans to reduce holdings by no more than 2% [1] - Saiwu Technology's shareholder Dongyun Chuangtou plans to reduce holdings by no more than 1% [1] - Kanglongda's shareholder Juyin Fund plans to reduce holdings by no more than 3% [1] - Zaiseng Technology's controlling shareholder Guo Mao has cumulatively reduced 9.45 million shares [1] - Weishi Electronics' controlling shareholder Watanabe Yōichi has reduced 0.89% of company shares [1] - Olin Bio's shareholder Shanghai Wushan has cumulatively reduced 3% of company shares [1] Group 2: Other Notable Events - Taifeng Pump Industry has terminated plans for a major asset restructuring [1] - Qingyue Technology is under investigation by the Securities Regulatory Commission for suspected false financial reporting [1] - Baismei's actual controller has received a notice of investigation from the Securities Regulatory Commission [1] - Taiyuan Car Factory will implement other risk warnings starting November 4 [1] - First Capital's subsidiary Yichuang Investment Bank has received a notice of investigation from the Securities Regulatory Commission [1]

Group 1 - The U.S. Treasury Secretary indicated that a U.S.-China trade agreement could be signed as early as next week, with China expressing willingness to work with the U.S. to implement the consensus reached by the two heads of state [1] - The public fund industry in China, valued at over 36 trillion yuan, is undergoing significant reforms, including guidelines for performance benchmarks that may lead to reduced compensation for fund managers whose long-term performance falls below benchmarks [1] Group 2 - The State Council is focusing on deepening reforms in key areas and expanding institutional openness, aiming to enhance market access and optimize regulatory frameworks for factor markets [2] - The People's Bank of China is working on optimizing the monetary policy framework and addressing market "herding effects," while also preparing policy tools to respond to macroeconomic and financial market fluctuations [2] - The Ministry of Finance plans to utilize special bonds and long-term government bonds effectively to encourage private capital participation in major projects and improve income distribution [2] Group 3 - The National Development and Reform Commission announced that 2 trillion yuan of the 5 trillion yuan local government debt limit will be allocated for new special bonds to support investment in certain provinces [3] - China's manufacturing PMI for October was reported at 49%, a decrease of 0.8 percentage points from the previous month, while the non-manufacturing PMI rose slightly to 50.1 [3] - A new action plan for smart city development aims to establish over 50 fully digital transformation cities by the end of 2027 [3] Group 4 - The China Securities Regulatory Commission (CSRC) is emphasizing the need for a more inclusive and adaptable capital market system during the 14th Five-Year Plan period, including reforms in the Sci-Tech Innovation Board and the Growth Enterprise Market [5] - The CSRC has taken a strict stance against misinformation in the capital market, reinforcing a "zero tolerance" policy towards false information dissemination [5] - A-shares experienced a decline, with the Shanghai Composite Index closing down 0.81% at 3954.79 points, while small-cap stocks saw a rebound [6] Group 5 - The Hong Kong Hang Seng Index closed down 1.43%, with technology stocks continuing to struggle, while healthcare stocks performed well [6] - The Shanghai Stock Exchange reported a year-on-year increase in net profit for listed companies in Q3, with significant growth in mergers and acquisitions since the introduction of new policies [6] - The Hong Kong Stock Exchange announced an expansion of the "Southbound ETF Connect" list, increasing the number of ETFs available for trading [7] Group 6 - The Ministry of Housing and Urban-Rural Development is reforming the real estate development and sales system to prevent delivery risks and protect buyers' rights [10] - The top 100 real estate companies in China reported a sales amount of 253 billion yuan in October, reflecting a year-on-year decrease of 41.9% [10] - The China Automotive Dealers Association reported an increase in the inventory warning index for October, indicating improved conditions in the automotive circulation industry [11]

Core Viewpoint - The actual controller of Beishimei, Chen Feng, has received a notice of investigation from the China Securities Regulatory Commission (CSRC) for failing to fulfill mandatory tender offer obligations and for violations of information disclosure regulations [1] Company Summary - Beishimei announced that Chen Feng resigned from all positions within the company over three months ago, including chairman and legal representative, due to work adjustments [1] - As of now, Chen Feng directly holds 966,400 shares of Beishimei and, together with his concerted actors, controls 29.37% of the company's equity, remaining the actual controller [1] - The company stated that the investigation pertains solely to Chen Feng as an individual and is unrelated to the daily operations and business activities of Beishimei, indicating no impact on the company's production and operations [1] Industry Summary - Beishimei is an environmentally friendly pesticide company, primarily engaged in the production and research of the environmentally friendly, efficient, and low-toxicity pesticide, Dimethenamid-P, including its raw materials, intermediates, and formulations [1] - The company is recognized as a leading player in the industry, possessing the full industrial chain production and research capabilities for Dimethenamid-P in China [1]